Intuitive Surgical makes the da Vinci surgical robot. The company was one of the first in the surgical robotics market and ...

Intuitive Surgical recently reported past first-quarter 2026 results showing revenue of US$2,770.8 million and net income of ...

This surgery stock stands to benefit greatly from demographic change and its impact on healthcare.

Robotic surgery’s market leader has had a rough start to 2026, but our model sees the pullback as an opportunity. Intuitive Surgical (NASDAQ:ISRG) trades at $482.22 after a 14.86% year-to-date decline ...

TheFly reported on April 13 that BTIG analyst Ryan Zimmerman lowered the price target for ISRG to $574 from $616 while maintaining a Buy rating.

Sovato CEO Brian Miller, who spent 25 years at Computer Motion and Intuitive Surgical, explains why remote surgery is ...

Intuitive Surgical's first-quarter results easily topped Wall Street's expectations.

Intuitive, a leader in robotic-assisted surgery, announced that the FDA has cleared its Vessel Sealer Curved, an advanced bipolar electrosurgical instrument designed for use with its da Vinci systems.

Intuitive Surgical executives said this week that general surgery, particularly in after-hours care, drove procedure growth for the da Vinci robotic platform. U.S. procedures increased 15% in the ...

Intuitive, a leader in robotic-assisted surgery, showcased its telesurgery capabilities during the Society of Robotic Surgery conference in Strasbourg, France, by connecting two surgeons across the ...

Intuitive Surgical stock jumped Wednesday after the robotic surgery giant easily beat first-quarter sales and earnings calls.